ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1631503
The Effect of Preventive Administration of metaraminol on Hypothermia and Shivering in Cesarean Section Patients Randomized Clinical Trial --A randomized controlled study
Provisionally accepted
- 1Second Hospital of Anhui Medical University, Hefei, Anhui Province, China
- 2The First Affiliated Hospital of Anhui University of Science and Technology, Huainan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Hypothermia is a common complication during cesarean section and may lead to a series of adverse outcomes. This study aims to evaluate whether prophylactic low-dose metaraminol infusion, compared to saline control, reduces intraoperative hypothermia and shivering in cesarean section patients under spinal anesthesia.Methods: This study is a randomized, double-blind, placebo-controlled trial, including a total of 66 full-term pregnant women scheduled for cesarean section under spinal anesthesia. Women were randomly divided into the metaraminol (n=33) and placebo (n=33). The metaraminol group was given a prophylactic infusion of metaraminol at a rate of 5 mg/h after the start of anesthesia until the end of surgery, while the placebo group was given an equal volume of saline. The primary outcome was the incidence of hypothermia, while secondary outcomes included the incidence of shivering, changes in rectal temperature, neonatal temperature, and the occurrence of hypotension and bradycardia. Result: Compared to the placebo group, the metaraminol group significantly reduced the incidence of hypothermia (54.0% vs. 81.0%, P=0.017) and shivering (27% vs. 57%, P=0.012). At the end of the surgery, the rectal temperature in the metaraminol group was significantly higher than that in the placebo group (36.72±0.31 °C vs. 36.50±0.26 °C, P=0.003). In addition, the incidence of hypotension was lower in the metaraminol group compared to the placebo group (6% vs. 24%, P=0.0039). Conclusion: Prophylactic infusion of low-dose metaraminol during spinal anesthesia for cesarean section can effectively reduce the incidence of hypothermia and shivering. It has a positive impact on maternal temperature and hemodynamic stability, offering a new and effective strategy for temperature management during cesarean section.
Keywords: Metaraminol, Hypothermia, Shivering, Cesarean Section, spinal anesthesia
Received: 19 May 2025; Accepted: 20 Jun 2025.
Copyright: © 2025 Yu, FENG, Lei, Zhang, Li, Shen, Shi, Minghong and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Liu Minghong, The First Affiliated Hospital of Anhui University of Science and Technology, Huainan, China
Rui Li, Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.